Format

Send to

Choose Destination
Biochem J. 1998 Aug 1;333 ( Pt 3):471-90.

Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling.

Author information

1
Department of Biochemistry and Molecular Biology, University College London, Gower Street, London WC1E 6BT, UK. p.shepard@biochem.ucl.ac.uk

Erratum in

  • Biochem J 1998 Nov 1;335(Pt 3):711.

Abstract

Insulin plays a key role in regulating a wide range of cellular processes. However, until recently little was known about the signalling pathways that are involved in linking the insulin receptor with downstream responses. It is now apparent that the activation of class 1a phosphoinositide 3-kinase (PI 3-kinase) is necessary and in some cases sufficient to elicit many of insulin's effects on glucose and lipid metabolism. The lipid products of PI 3-kinase act as both membrane anchors and allosteric regulators, serving to localize and activate downstream enzymes and their protein substrates. One of the major ways these lipid products of PI 3-kinase act in insulin signalling is by binding to pleckstrin homology (PH) domains of phosphoinositide-dependent protein kinase (PDK) and protein kinase B (PKB) and in the process regulating the phosphorylation of PKB by PDK. Using mechanisms such as this, PI 3-kinase is able to act as a molecular switch to regulate the activity of serine/threonine-specific kinase cascades important in mediating insulin's effects on endpoint responses.

PMID:
9677303
PMCID:
PMC1219607
DOI:
10.1042/bj3330471
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center